EH is a complex disorder that results from the interaction of multiple genetic and environmental factors. These lines of evidence strongly hint that gene–gene as well as gene–environment interactions ...

April 28, 2010 — The US Food and Drug Administration (FDA) approved in March safety labeling revisions for a fixed-dose combination capsule containing the dihydropyridine calcium channel blocker ...